Depression care for US prostate cancer patients: more QALYs, lower cost

  • PDF / 167,266 Bytes
  • 1 Pages / 595.245 x 841.846 pts (A4) Page_size
  • 79 Downloads / 165 Views

DOWNLOAD

REPORT

1173-5503/20/0866-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 14 Nov 2020 No. 866

1

Data Loading...

Recommend Documents
Ixekizumab in psoriatic arthritis: more QALYs, lower cost in Spain

193 86 166KB

Guideline-based stepped care not cost effective for depression

171 104 184KB

The health care cost of palliative care for cancer patients: a systematic review

161 51 698KB

Radiopharmaceuticals for Prostate Cancer

162 119 7MB

Long-term unmet supportive care needs of prostate cancer survivors: 15-year follow-up from the NSW Prostate Cancer Care

161 0 347KB

Screening for Prostate Cancer

200 16 544KB

The Prostate Cancer Dilemma Selecting Patients for Active Surveillan

148 97 7MB

Radiotherapy for Prostate Cancer

199 8 7MB

Teledermatology triage system cost saving in US managed-care setting

160 52 167KB

Pegfilgrastim more cost effective than filgrastim in breast cancer

105 70 124KB

Surgical Techniques for Prostate Cancer

154 70 6MB

Prostate Cancer

178 43 9MB